Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation

This article was originally published in The Tan Sheet

Executive Summary

Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg
Advertisement

Related Content

FTC Consumer Chief Vladeck’s Reputation Precedes Him
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Kessler Hails Leadership, Torti Praises Staff For Brighter Future At FDA
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
FDA Scientists Say Plan B Decision-Makers At CDER “Should Be Removed”
HHS Public Health Pick Could Accelerate Tobacco, Sunscreen Oversight
Plan B Ruling: Little Commercial Impact, Big Policy Implications
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
Hamburg/Sharfstein Choice Underscores Public Health, Food Safety
Hamburg/Sharfstein Choice Underscores Public Health, Food Safety

Topics

Advertisement
UsernamePublicRestriction

Register

PS102760

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel